BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

722 related articles for article (PubMed ID: 34811761)

  • 1. Emerging SARS-CoV-2 variants can potentially break set epidemiological barriers in COVID-19.
    Kumar A; Parashar R; Kumar S; Faiq MA; Kumari C; Kulandhasamy M; Narayan RK; Jha RK; Singh HN; Prasoon P; Pandey SN; Kant K
    J Med Virol; 2022 Apr; 94(4):1300-1314. PubMed ID: 34811761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SARS-CoV-2 Entry Related Viral and Host Genetic Variations: Implications on COVID-19 Severity, Immune Escape, and Infectivity.
    Huang SW; Wang SF
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33802729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Feasible Alternative Strategy Targeting Furin Disrupts SARS-CoV-2 Infection Cycle.
    Mondal T; Shivange G; Habieb A; Tushir-Singh J
    Microbiol Spectr; 2022 Feb; 10(1):e0236421. PubMed ID: 35138160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variants in ACE2; potential influences on virus infection and COVID-19 severity.
    Bakhshandeh B; Sorboni SG; Javanmard AR; Mottaghi SS; Mehrabi MR; Sorouri F; Abbasi A; Jahanafrooz Z
    Infect Genet Evol; 2021 Jun; 90():104773. PubMed ID: 33607284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Haplotype distribution of SARS-CoV-2 variants in low and high vaccination rate countries during ongoing global COVID-19 pandemic in early 2021.
    Bui NN; Lin YT; Huang SH; Lin CW
    Infect Genet Evol; 2022 Jan; 97():105164. PubMed ID: 34848355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluating angiotensin-converting enzyme 2-mediated SARS-CoV-2 entry across species.
    Zhang HL; Li YM; Sun J; Zhang YY; Wang TY; Sun MX; Wang MH; Yang YL; Hu XL; Tang YD; Zhao J; Cai X
    J Biol Chem; 2021; 296():100435. PubMed ID: 33610551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural Evaluation of the Spike Glycoprotein Variants on SARS-CoV-2 Transmission and Immune Evasion.
    Salleh MZ; Derrick JP; Deris ZZ
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SARS-CoV-2 spike protein receptor-binding domain N-glycans facilitate viral internalization in respiratory epithelial cells.
    Zheng L; Ma Y; Chen M; Wu G; Yan C; Zhang XE
    Biochem Biophys Res Commun; 2021 Nov; 579():69-75. PubMed ID: 34592572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SARS-CoV-2 Variants of Concern and Variants of Interest Receptor Binding Domain Mutations and Virus Infectivity.
    Liu H; Wei P; Kappler JW; Marrack P; Zhang G
    Front Immunol; 2022; 13():825256. PubMed ID: 35154144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross-Neutralization of Emerging SARS-CoV-2 Variants of Concern by Antibodies Targeting Distinct Epitopes on Spike.
    Changrob S; Fu Y; Guthmiller JJ; Halfmann PJ; Li L; Stamper CT; Dugan HL; Accola M; Rehrauer W; Zheng NY; Huang M; Wang J; Erickson SA; Utset HA; Graves HM; Amanat F; Sather DN; Krammer F; Kawaoka Y; Wilson PC
    mBio; 2021 Dec; 12(6):e0297521. PubMed ID: 34781736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging mutation patterns in SARS-CoV-2 variants.
    Ostrov DA; Knox GW
    Biochem Biophys Res Commun; 2022 Jan; 586():87-92. PubMed ID: 34837837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural and antigenic variations in the spike protein of emerging SARS-CoV-2 variants.
    Mittal A; Khattri A; Verma V
    PLoS Pathog; 2022 Feb; 18(2):e1010260. PubMed ID: 35176090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive mapping of binding hot spots of SARS-CoV-2 RBD-specific neutralizing antibodies for tracking immune escape variants.
    Yi C; Sun X; Lin Y; Gu C; Ding L; Lu X; Yang Z; Zhang Y; Ma L; Gu W; Qu A; Zhou X; Li X; Xu J; Ling Z; Xie Y; Lu H; Sun B
    Genome Med; 2021 Oct; 13(1):164. PubMed ID: 34649620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential Interactions between Human ACE2 and Spike RBD of SARS-CoV-2 Variants of Concern.
    Kim S; Liu Y; Lei Z; Dicker J; Cao Y; Zhang XF; Im W
    J Chem Theory Comput; 2021 Dec; 17(12):7972-7979. PubMed ID: 34856802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evolutionary and structural analysis elucidates mutations on SARS-CoV2 spike protein with altered human ACE2 binding affinity.
    Chakraborty S
    Biochem Biophys Res Commun; 2021 Jan; 534():374-380. PubMed ID: 33272568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced Binding of SARS-CoV-2 Spike Protein to Receptor by Distal Polybasic Cleavage Sites.
    Qiao B; Olvera de la Cruz M
    ACS Nano; 2020 Aug; 14(8):10616-10623. PubMed ID: 32806067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SARS-CoV-2 spike L452R variant evades cellular immunity and increases infectivity.
    Motozono C; Toyoda M; Zahradnik J; Saito A; Nasser H; Tan TS; Ngare I; Kimura I; Uriu K; Kosugi Y; Yue Y; Shimizu R; Ito J; Torii S; Yonekawa A; Shimono N; Nagasaki Y; Minami R; Toya T; Sekiya N; Fukuhara T; Matsuura Y; Schreiber G; ; Ikeda T; Nakagawa S; Ueno T; Sato K
    Cell Host Microbe; 2021 Jul; 29(7):1124-1136.e11. PubMed ID: 34171266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epitope Classification and RBD Binding Properties of Neutralizing Antibodies Against SARS-CoV-2 Variants of Concern.
    Deshpande A; Harris BD; Martinez-Sobrido L; Kobie JJ; Walter MR
    Front Immunol; 2021; 12():691715. PubMed ID: 34149735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Computational Analysis of Mutations in the Receptor-Binding Domain of SARS-CoV-2 Spike and Their Effects on Antibody Binding.
    Bozdaganyan ME; Shaitan KV; Kirpichnikov MP; Sokolova OS; Orekhov PS
    Viruses; 2022 Jan; 14(2):. PubMed ID: 35215888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutational landscape and in silico structure models of SARS-CoV-2 spike receptor binding domain reveal key molecular determinants for virus-host interaction.
    Nelson-Sathi S; Umasankar PK; Sreekumar E; Nair RR; Joseph I; Nori SRC; Philip JS; Prasad R; Navyasree KV; Ramesh S; Pillai H; Ghosh S; Santosh Kumar TR; Pillai MR
    BMC Mol Cell Biol; 2022 Jan; 23(1):2. PubMed ID: 34991443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.